Right-Sizing Technology in the Era of Consumer-Driven Health Care

Deák, Eszter; Marlowe, Elizabeth M.

doi:10.1016/j.clinmicnews.2017.07.001

Cited by 1 publication

(1 citation statement)

References 39 publications

(40 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, there are FDA-approved Chlamydia trachomatis / Neisseria gonnorrhea NAAT assays for vaginal specimens self-collected in clinical settings, and specimen self-collection is also being explored for mail-in testing. 28 Given the need for social distancing in the era of COVID-19, the National Coalition of STD Directors noted that “home-based testing and consultation for STI care and conditions makes absolute sense.” 29 For females, self-collection of vaginal swabs for STI testing has been reported to be valid and acceptable for a number of STIs, including Neisseria gonorrhoeae , Chlamydia trachomatis , Trichomonas vaginalis, and Mycoplasma genitalium, as well as for agents of vaginitis/vaginosis. 30–33 A recent meta-analysis found that programs offering self-collection of swab specimens for STI testing (chlamydia, gonorrhea, or trichomonas) significantly increased rates of participation in STI testing (relative risk [RR] 2.94; 95% CI 1.19 to 7.28) and detection of infection (RR 2.17; 95% CI 1.04 to 4.50).…”

Section: Current and Future State Of Self-collection And Self-testingmentioning

confidence: 99%

Evolution of Specimen Self-Collection in the COVID-19 Era: Implications for Population Health Management of Infectious Disease

Cockerill

Wohlgemuth

Radcliff

et al. 2021

Population Health Management

Self Cite

View full text Add to dashboard Cite

Laboratory testing is an important component in the diagnosis of respiratory tract infections such as with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). However, specimen collection not only risks exposure of health care workers and other patients to infection, but also necessitates use of personal protective equipment that may be in short supply during periods of heightened disease activity. Self-collection of nasal or oropharyngeal swabs offers an alternative to address these drawbacks. Although studies in the past decade have demonstrated the utility of this approach for respiratory infections, it has not been widely adopted in routine clinical practice. The rapid spread of coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has focused attention on the need for safe, convenient, timely, and scalable methods for collecting upper respiratory specimens for testing. The goals of this article are to highlight the literature regarding self-collected nasal or oropharyngeal specimens for respiratory pathogen testing; discuss the role of self-collection in helping prevent the spread of the COVID-19 disease from infected patients and facilitating a shift toward “virtual” medicine or telemedicine; and describe the current and future state of self-collection for infectious agents, and the impacts these approaches can have on population health management and disease diagnosis and prevention.

show abstract

Section: Current and Future State Of Self-collection And Self-testingmentioning

confidence: 99%